| AAV | Adeno-associated virus |
| AEs | Adverse effects |
| ARL3 | ADP-ribosylation factor-like GTPase 3 |
| CME | Cystoid macular edema |
| dB | Decibels |
| GAP | GTPase-activating protein |
| GEF | Guanine nucleotide exchange factor |
| GRK1 | G protein-coupled receptor kinase 1 |
| IRBP | Interphotoreceptor retinoid-binding protein |
| iPSCs | Induced pluripotent stem cells |
| KO | Knockout |
| LCA | Leber congenital amaurosis |
| MAIA | Macular integrity assessment |
| nAbs | Neutralizing antibodies |
| ONL | Outer nuclear layer |
| PAM | Protospacer adjacent motif |
| PDE δ | Phosphodiesterase δ |
| RGCs | Retinal ganglion cells |
| rAAV | Recombinant AAV |
| ROS | Retinal organoids |
| RPE | Retinal pigment epithelium |
| RP | Retinitis pigmentosa |
| RPGR | Retinitis pigmentosa GTPase regulator |
| ROS | Reactive oxygen species |
| sgRNA | Single guide RNA |
| TEAEs | Treatment-emergent adverse events |
| TLRs | Toll-like receptors |
| UNC119 | Uncoordinated 119 protein |
| VF | Visual field |
| VEGF | Vascular endothelial growth factor |
| XLRP | X-linked retinitis pigmentosa |